Although many trials demonstrated statistically significant differences between groups in terms of weight loss in favour of sibutramine versus placebo, the differences may not always be of clinical significance. The clinical significance of between-group differences for secondary outcomes may also be debatable. Possible adverse effects should be taken into account when prescribing sibutramine.